181 related articles for article (PubMed ID: 7073736)
1. The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats.
Ehlert FJ; Itoga E; Roeske WR; Yamamura HI
Biochem Biophys Res Commun; 1982 Feb; 104(3):937-43. PubMed ID: 7073736
[No Abstract] [Full Text] [Related]
2. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
[TBL] [Abstract][Full Text] [Related]
3. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic localization of a calcium channel antagonist, [3H]nitrendipine, binding site in rat brain.
Quirion R
Neurosci Lett; 1983 Apr; 36(3):267-71. PubMed ID: 6866333
[TBL] [Abstract][Full Text] [Related]
5. Binding of the calcium channel blocker nitrendipine to its receptor in purified sarcolemma from canine cardiac ventricle.
Sarmiento JG; Janis RA; Colvin RA; Triggle DJ; Katz AM
J Mol Cell Cardiol; 1983 Feb; 15(2):135-7. PubMed ID: 6304327
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
Schoemaker H; Boles RG; Roeske WR; Yamamura HI
Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
[No Abstract] [Full Text] [Related]
7. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
Gopalakrishnan V; Triggle CR
Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
[TBL] [Abstract][Full Text] [Related]
8. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
Schwartz J; Velly J
Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
[TBL] [Abstract][Full Text] [Related]
9. Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes.
Yamamura HI; Schoemaker H; Boles RG; Roeske WR
Biochem Biophys Res Commun; 1982 Sep; 108(2):640-6. PubMed ID: 6293498
[No Abstract] [Full Text] [Related]
10. Potent enhancement of [3H]nitrendipine binding in rat cerebral cortical and cardiac homogenates: a putative mechanism for the action of MDL 12,330A.
Lee HR; Jaros JA; Roeske WR; Wiech NL; Ursillo R; Yamamura HI
J Pharmacol Exp Ther; 1985 Jun; 233(3):611-6. PubMed ID: 3159884
[TBL] [Abstract][Full Text] [Related]
11. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
Boles RG; Yamamura HI; Schoemaker H; Roeske WR
J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
[TBL] [Abstract][Full Text] [Related]
12. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
Schoemaker H; Langer SZ
Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
Bellemann P
J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
[TBL] [Abstract][Full Text] [Related]
14. Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
Gould RJ; Murphy KM; Snyder SH
Mol Pharmacol; 1984 Mar; 25(2):235-41. PubMed ID: 6422256
[TBL] [Abstract][Full Text] [Related]
15. Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites.
Bristow MR; Ginsburg R; Laser JA; McAuley BJ; Minobe W
Br J Pharmacol; 1984 Jun; 82(2):309-20. PubMed ID: 6329392
[TBL] [Abstract][Full Text] [Related]
16. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
Schoemaker H; Langer SZ
J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412
[TBL] [Abstract][Full Text] [Related]
18. High affinity binding of a calcium channel antagonist to smooth and cardiac muscle.
Bolger GT; Gengo PJ; Luchowski EM; Siegel H; Triggle DJ; Janis RA
Biochem Biophys Res Commun; 1982 Feb; 104(4):1604-9. PubMed ID: 7073757
[No Abstract] [Full Text] [Related]
19. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site.
Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC
J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730
[TBL] [Abstract][Full Text] [Related]
20. Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites.
Quirion R; Lafaille F; Nair NP
J Pharm Pharmacol; 1985 Jun; 37(6):437-40. PubMed ID: 2410588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
